Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia
NCT00563446
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
OTHER_GOV
Sponsor class
Conditions
Anemia
Kidney Failure, Chronic
Peritoneal Dialysis, Continuous Ambulatory
Interventions
DRUG:
Darbepoetin alfa
Sponsor
Hospital Authority, Hong Kong
Collaborators
[object Object]